HopeStage
Back to all studies
TerminatedNCT05193318

KAP for Depression in Abstinent Opioid Users

Medication studyAges 18–64United States
The study in practice

Understand this study

Who could participate?

Listed age limits: 18 years to 64 years.

Listed locations
CharlestonSee all locations and recruitment
Study phase
Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.

Get this study by email

HopeStage may email me about this study.
Loading the security check...

What to know before participating

A point to clarify

This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?

Study clarity

Things to check before joining

Study start dateStarted: January 13, 2022
Recruitment status
Terminated
Enrollment listed in the registry
5
Sponsor
Medical University of South Carolina
Sponsor type
University
Study type
Drug
Intervention type
Drug
Study phase
Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
Locations
United States
Age range
From 18 Years to 64 Years
Official registry ID
NCT05193318
Official title
Show the full official title

Ketamine-assisted Psychotherapy for the Treatment of Persistent Depression in Abstinent Opioid Users

Recruitment & locations

Terminated

Charleston

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

Who is behind this study?

The study sponsor is Medical University of South Carolina, a university.

Does this study involve medication?

Yes. The study involves medication, including Ketamine-assisted psychotherapy.

Who can participate?

Listed age limits: 18 years to 64 years.

Is this study still recruiting?

The registry lists this study as terminated.

Want to explore more studies?

Explore studies